AnkitAjitDesaiMDFAHA
Cardiology • Indianapolis, INEchocardiography, Vascular Medicine, Cardiovascular Disease Genetics
Professor, Medicine, Indiana University, Indianapolis, IN
Overview of Dr. Desai
Dr. Ankit Desai is a cardiologist in Indianapolis, IN and is affiliated with Indiana University Health University Hospital. He received his medical degree from University of Illinois College of Medicine and has been in practice 14 years. He also speaks multiple languages, including English, Gujarati, Hindi, and Spanish. He specializes in adult heart disease, pulmonary vascular medicine, sickle cell disease, and cardiovascular genetics and is experienced in pulmonary hypertension, sickle-cell anemia, and medical genetics.
Office
1801 N Senate Blvd
# Sutie
Indianapolis, IN 46202Fax+1 317-962-9657
Education & Training
University of ChicagoFellowship, Cardiovascular Disease, 2008 - 2010
California Pacific Medical CenterResidency, Internal Medicine, 2003 - 2006
University of Illinois College of MedicineClass of 2003
Certifications & Licensure
IN State Medical License 2018 - 2025
AZ State Medical License 2014 - 2020
IL State Medical License 2006 - 2014
CA State Medical License 2003 - 2006- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.Jason Hong, Lejla Medzikovic, Wasila Sun, Brenda Wong, Grégoire Ruffenach
Circulation. 2024-10-15 - 1 citationsDeficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension.Haiyang Tang, Akash Gupta, Seth A Morrisroe, Changlei Bao, Tae-Hwi Schwantes-An
Circulation. 2024-07-23 - Plasma Proteomics Identifies B2M as a Regulator of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction.Jia-Rong Jheng, Jacqueline T DesJardin, Yi-Yun Chen, Joshua R Huot, Yang Bai
Arteriosclerosis, Thrombosis, and Vascular Biology. 2024-07-01
Press Mentions
Early Researchers Engage in Molecular and Technology-Driven Cardiovascular ResearchDecember 4th, 2024- New Insights and Potential Treatments for Pulmonary HypertensionAugust 21st, 2024
- Beta Blocker Used to Treat Heart Problems and Other Medical Concerns Could Be New Treatment for Sickle Cell CardiomyopathyJanuary 5th, 2024
- Join now to see all
Grant Support
- Sickle cell diseaseNHLBI2017–2022
Professional Memberships
- Fellow
- Fellow
- Member
- Pulmonary Hypertension AssociationScientific Leadership Council Member
- Member
- Pulmonary hypertension breakthrough initiativeMember
Other Languages
- Gujarati, Hindi, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
